You can buy or sell Natus Medical and other stocks, options, ETFs, and crypto commission-free!
Natus Medical, Inc. engages in the provision of newborn care, neurology, and hearing and balance assessment healthcare products and services. Its products are used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. Read More The company was founded by Maurizio Liverani, John Robert Camber Porter, William New, Jr., Brian Prinn and William W. Moore on May 26, 1987 and is headquartered in Pleasanton, CA.
52 Week High
52 Week Low
Present Technicals: Natus Medical (NASDAQ: BABY)
Natus Medical is in the healthcare sector and medical devices industry. Natus Medical Inc provides newborn care, neurology healthcare products and services used for screening, diagnosis, detection, treatment, monitoring and tracking of medical ailments in newborn care, epilepsy, and balance and mobility disorders. Previous Intraday Trading Performance: The BABY stock showed a previous change of -0.41% with an open at 27.03 and a close of 26.92. It reached an intraday high of 27.33 and a low of 26.71. Bus...
Stock Price, News, & Analysis for Natus Medical
Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide.
Markets InsiderMar 1
Natus Announces Upcoming Financial Conference Schedule
PLEASANTON, Calif., March 01, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY) today announced its upcoming conference schedule for March: Raymond James 40 th Annual Institutional Investors Conference Jonathan Kennedy, CEO Orlando, FL Monday, March 4, 2019 7:30 a.m. ET (4:30 a.m. PT) and available for one-on-one meetings throughout the day Jonathan Kennedy, CEO Orlando, FL Monday, March 4, 2019 7:30 a.m. ET (4:30 a.m. PT) and available for one-on-one meetings throughout the day 3...
Expected Apr 24, Pre-Market